Comparison of Bleeding Complications With Omega-3 Fatty Acids + Aspirin + Clopidogrel-Versus-Aspirin + Clopidogrel in Patients With Cardiovascular Disease

American Journal of Cardiology

Volumn 104, Issue 8, 2009, Pages 1052-1054

  Watson, Pauline D ^a   Joy, Parijat S ^a   Nkonde, Chileshe ^a   Hessen, Scott E ^a   Karalis, Dean G ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG MEGADOSE; FEMALE; FOLLOW UP; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ASPIRIN; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; TICLOPIDINE; UNITED STATES;

EID: 70349485059     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.05.055     Document Type: Article

References (12)

1. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey D.E., Chavey W.E., Fesmire F.M., Hochman J.S., Levin T.N., Lincoff A.M., Peterson E.D., Theroux P., Wenger N.K., and Wright R.S. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction-executive summary. J Am Coll Cardiol 50 (2007) 652-726
2. Bhatt D.L., Fox K.A., Hacke W., Berger P.B., Black H.R., Boden W.E., Cacoub P., Cohen E.A., Creager M.A., Easton J.D., Flather M.D., Haffner S.M., Hamm C.W., Hankey G.J., Johnston S.C., Mak K.H., Mas J.L., Montalescot G., Pearson T.A., Steg P.G., Steinhubl S.R., Weber M.A., Brennan D.M., Fabry-Ribaudo L., Booth J., and Topol E.J. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 (2006) 1706-1717
3. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
4. Aronow H.D., Steinhubl S.R., Brennan D.M., Berger P.B., and Topol E.J. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Am Heart J 157 (2009) 369-374
5. Burr M.L., Fehily A.M., Gilbert J.F., Rogers S., Holliday R.M., Sweetnam P.M., Elwood P.C., and Deadman N.M. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet 2 (1989) 757-761
6. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
7. Yokoyama M., Origasa H., Matsuzaki M., Matsuzawa Y., Saito Y., Ishikawa Y., Oikawa S., Sasaki J., Hishida H., Itakura H., Kita T., Kitabatake A., Nakaya N., Sakata T., Shimada K., and Shirato K. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369 (2007) 1090-1098
8. GISSI-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372 (2008) 1223-1230
9. Knapp H.R., Reilly I.A., Alessandrini P., and FitzGerald G.A. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 314 (1986) 937-942
10. Eritsland J., Arnesen H., Gronseth K., Fjeld N.B., and Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 77 (1996) 31-36
11. Leaf A., Jorgensen M.B., Jacobs A.K., Cote G., Schoenfeld D.A., Scheer J., Weiner B.H., Slack J.D., Kellet M.A., Raizner A.E., Weber P.C., Mahrer P.R., and Rossouw J.E. Do fish oils prevent restenosis after coronary angioplasty?. Circulation 90 (1994) 2248-2257
12. Bender N.K., Kraynak M.A., Chiquette E., Linn W.D., Clark G.M., and Bussey H.I. Effects of marine fish oils on the anticoagulation status of patients receiving chronic warfarin therapy. J Thromb Thrombolysis 5 (1998) 257-261